{"url_path":"/sec/tnxp/8-k/2026-06-29/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 ** **Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1430306/0001493152-26-030408-index.html","accession_number":"0001493152-26-030408","cik":"0001430306","ticker":"TNXP","issuer_name":"Tonix Pharmaceuticals Holding Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1430306/0001493152-26-030408-index.html","primary_entity_key":"0001430306","primary_entity_name":"Tonix Pharmaceuticals Holding Corp."},"word_count":21,"has_tables":true,"body_markdown":"**Item 8.01** **Other Events.**\n\n \n\nOn\nJune 29, 2026, the Company announced that the first participant was enrolled in the HORIZON Study."}